Authors:
DEGAST GC
HAAGEN IA
VANHOUTEN AA
KLEIN SC
DUITS AJ
DEWEGER RA
VROOM TM
CLARK MR
PHILLIPS J
VANDIJK AJG
DELAU WBM
BAST BJEG
Citation: Gc. Degast et al., CD8 T-CELL ACTIVATION AFTER INTRAVENOUS ADMINISTRATION OF CD3XCD19 BISPECIFIC ANTIBODY IN PATIENTS WITH NON-HODGKIN-LYMPHOMA, Cancer immunology and immunotherapy, 40(6), 1995, pp. 390-396
Authors:
HAAGEN IA
GEERARS AJG
DELAU WBM
BAST BJEG
DEGAST C
Citation: Ia. Haagen et al., THE EFFICACY OF CD3 X CD19 BISPECIFIC MONOCLONAL-ANTIBODY (BSAB) IN ACLONOGENIC-ASSAY - THE EFFECT OF REPEATED ADDITION OF BSAB AND INTERLEUKIN-2, Blood, 85(11), 1995, pp. 3208-3212
Authors:
HAAGEN IA
DELAU WBM
BAST BJEG
GEERARS AJG
CLARK MR
DEGAST BC
Citation: Ia. Haagen et al., UNPRIMED CD4-CELLS CAN BE RAPIDLY ACTIVATED BY A CD3-X-CD19 BISPECIFIC ANTIBODY TO PROLIFERATE AND BECOME CYTOTOXIC( AND CD8+ T), Cancer immunology and immunotherapy, 39(6), 1994, pp. 391-396
Authors:
DELAU WBM
KUIPERS J
VOSHOL H
CLEVERS H
BAST BJEG
Citation: Wbm. Delau et al., HB4 ANTIBODY RECOGNIZES A CARBOHYDRATE STRUCTURE ON LYMPHOCYTE SURFACE-PROTEINS RELATED TO HB6, CDW75, AND CD76 ANTIGENS, The Journal of immunology, 150(11), 1993, pp. 4911-4919